JP2025106480A5 - - Google Patents

Info

Publication number
JP2025106480A5
JP2025106480A5 JP2025064597A JP2025064597A JP2025106480A5 JP 2025106480 A5 JP2025106480 A5 JP 2025106480A5 JP 2025064597 A JP2025064597 A JP 2025064597A JP 2025064597 A JP2025064597 A JP 2025064597A JP 2025106480 A5 JP2025106480 A5 JP 2025106480A5
Authority
JP
Japan
Prior art keywords
micelle
units
moiety
positively charged
portion comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025064597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025106480A (ja
Filing date
Publication date
Priority claimed from PCT/IB2020/056093 external-priority patent/WO2020261227A1/en
Application filed filed Critical
Publication of JP2025106480A publication Critical patent/JP2025106480A/ja
Publication of JP2025106480A5 publication Critical patent/JP2025106480A5/ja
Pending legal-status Critical Current

Links

JP2025064597A 2019-06-26 2025-04-09 ミセルナノ粒子及びその使用 Pending JP2025106480A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962867097P 2019-06-26 2019-06-26
US62/867,097 2019-06-26
US202063043693P 2020-06-24 2020-06-24
US63/043,693 2020-06-24
PCT/IB2020/056093 WO2020261227A1 (en) 2019-06-26 2020-06-26 Micellar nanoparticles and uses thereof
JP2021577297A JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021577297A Division JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用

Publications (2)

Publication Number Publication Date
JP2025106480A JP2025106480A (ja) 2025-07-15
JP2025106480A5 true JP2025106480A5 (enExample) 2025-07-25

Family

ID=74060198

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577297A Active JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用
JP2025064597A Pending JP2025106480A (ja) 2019-06-26 2025-04-09 ミセルナノ粒子及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021577297A Active JP7665540B2 (ja) 2019-06-26 2020-06-26 ミセルナノ粒子及びその使用

Country Status (14)

Country Link
US (3) US20220257790A1 (enExample)
EP (2) EP4603589A3 (enExample)
JP (2) JP7665540B2 (enExample)
KR (2) KR102658962B1 (enExample)
CN (1) CN114514038B (enExample)
AU (1) AU2020303447A1 (enExample)
BR (1) BR112021026365A2 (enExample)
CA (1) CA3144333A1 (enExample)
CO (1) CO2022000316A2 (enExample)
DK (1) DK3990028T3 (enExample)
IL (1) IL289258A (enExample)
MX (1) MX2022000045A (enExample)
PE (1) PE20220902A1 (enExample)
WO (1) WO2020261227A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10844380B1 (en) 2019-06-17 2020-11-24 Biorchestra Co., Ltd. Uses for prevention or treatment of brain diseases using microrna
MX2022009447A (es) * 2020-02-07 2022-11-09 Biorchestra Co Ltd Uso de inhibidores de micro ácido ribonucleico 485 (miarn 485) para tratamiento de tauopatía.
US11761874B2 (en) * 2020-05-15 2023-09-19 Saudi Arabian Oil Company CMC-based method for surfactant concentration determination
US20230301909A1 (en) * 2020-10-09 2023-09-28 The University Of Tokyo Nicotinamide-encapsulating micelles, and pregnancy-induced hypertension syndrome therapy composition containing nicotinamide-encapsulating micelles
KR20230128298A (ko) * 2020-12-30 2023-09-04 주식회사 바이오오케스트라 미셀 나노입자 및 이의 용도
EP4551193A1 (en) * 2022-07-07 2025-05-14 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
CN115721608A (zh) * 2022-11-29 2023-03-03 陕西科技大学 一种靶向温度敏感性聚合物胶束、制备方法及应用
WO2024228119A1 (en) * 2023-05-01 2024-11-07 Biorchestra Co., Ltd. Mirna-485 inhibitors
WO2024228118A1 (en) * 2023-05-01 2024-11-07 Biorchestra Co., Ltd. Mirna-485 inhibitors
WO2025149946A1 (en) * 2024-01-10 2025-07-17 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
KR100909681B1 (ko) 2000-12-01 2009-07-29 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
CA2492080A1 (en) * 2002-06-26 2004-01-08 Medigene Oncology Gmbh Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
EP1648914A4 (en) 2003-07-31 2009-12-16 Regulus Therapeutics Inc OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
US20050142581A1 (en) 2003-09-04 2005-06-30 Griffey Richard H. Microrna as ligands and target molecules
AU2005216251B2 (en) 2004-02-23 2011-03-10 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
WO2006093526A2 (en) 2004-07-21 2006-09-08 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a modified or non-natural nucleobase
US20080213891A1 (en) 2004-07-21 2008-09-04 Alnylam Pharmaceuticals, Inc. RNAi Agents Comprising Universal Nucleobases
US7632932B2 (en) 2004-08-04 2009-12-15 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
WO2007021896A2 (en) 2005-08-10 2007-02-22 Alnylam Pharmaceuticals, Inc. Chemically modified oligonucleotides for use in modulating micro rna and uses thereof
DE602006019455D1 (de) 2005-08-29 2011-02-17 Regulus Therapeutics Inc Verfahren für mir-122a-modulation
DK1931780T3 (en) 2005-08-29 2016-01-25 Regulus Therapeutics Inc Antisense-forbindelser med forøget anti-microrna-aktivitet
JP5213723B2 (ja) 2006-01-27 2013-06-19 アイシス ファーマシューティカルズ， インコーポレーテッド マイクロｒｎａの調節に使用するためのオリゴマー化合物及び組成物
MX2008012219A (es) 2006-04-03 2008-10-02 Santaris Pharma As Composicion farmaceutica que comprende oligonucleotidos antisentido anti-miarn.
ES2569558T3 (es) 2006-04-03 2016-05-11 Roche Innovation Center Copenhagen A/S Composición farmacéutica que comprende oligonucleótidos antisentido anti-ARNmi
EP2090665A2 (en) 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
WO2008074328A2 (en) 2006-12-21 2008-06-26 Exiqon A/S Microrna target site blocking oligos and uses thereof
WO2008113832A2 (en) 2007-03-22 2008-09-25 Santaris Pharma A/S SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF TARGET mRNA
AU2008306327B2 (en) 2007-10-04 2014-05-15 Roche Innovation Center Copenhagen A/S Micromirs
US20090156459A1 (en) * 2007-11-16 2009-06-18 Pharmain Corporation Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
US8541435B2 (en) * 2008-07-11 2013-09-24 Uday Saxena Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)
JP5622254B2 (ja) * 2009-03-31 2014-11-12 国立大学法人東京大学 二本鎖リボ核酸ポリイオンコンプレックス
WO2010122538A1 (en) 2009-04-24 2010-10-28 Santaris Pharma A/S Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon
LT2459220T (lt) * 2009-07-31 2020-12-28 Ascendis Pharma A/S Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
AU2010292329B2 (en) * 2009-09-09 2016-07-21 Pharmain Corporation Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
US20120005765A1 (en) * 2010-07-01 2012-01-05 Saint Louis University Animal model for parkinson's disease
ES2793481T3 (es) 2010-09-24 2020-11-16 Zoetis Services Llc Oximas de isoxazolina como agentes antiparasitarios
US20140371292A1 (en) * 2011-08-10 2014-12-18 Ludwig-Maximilians-Universitat Munchen Method for the controlled intracellular delivery of nucleic acids
CN113274506A (zh) * 2013-12-05 2021-08-20 念·吴 聚合物-碳水化合物的缀合物的药物转递技术
CN106456662A (zh) * 2014-02-24 2017-02-22 奥利金制药公司 口服给药的戊聚糖多硫酸盐的组合物及其使用方法
WO2016086177A2 (en) * 2014-11-25 2016-06-02 Drexel University Compositions and methods for hiv quasi-species excision from hiv-1-infected patients
WO2017086467A1 (ja) * 2015-11-19 2017-05-26 公立大学法人名古屋市立大学 抗腫瘍性ドラッグデリバリー製剤
US20190336608A1 (en) * 2016-06-09 2019-11-07 Curevac Ag Cationic carriers for nucleic acid delivery
CN110392583B (zh) 2016-09-15 2023-01-03 加利福尼亚大学董事会 改进的杂化的末端树枝状聚合物
RU2016146594A (ru) * 2016-11-28 2018-05-28 Общество С Ограниченной Ответственностью "Биофарм-Меморейн" Средство для лечения деменции различной этиологии
CA3045131A1 (en) 2016-12-14 2018-06-21 Ligandal, Inc. Methods and compositions for nucleic acid and protein payload delivery
WO2018139759A1 (ko) * 2017-01-26 2018-08-02 주식회사 바이오오케스트라 마이크로 rna를 이용한 알츠하이머병 진단방법
WO2018144022A1 (en) 2017-02-03 2018-08-09 Farokhzad Omid C Particles as delivery systems
CN110156971A (zh) 2018-02-13 2019-08-23 上海时莱生物技术有限公司 一种两亲性嵌段共聚物及其制备方法和纳米胶束载药系统
WO2019204799A1 (en) 2018-04-20 2019-10-24 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
CN111632153B (zh) 2020-06-23 2023-02-24 宁夏医科大学 一种化学基因药物共载的靶向纳米递药系统及其制备方法
KR20230128298A (ko) 2020-12-30 2023-09-04 주식회사 바이오오케스트라 미셀 나노입자 및 이의 용도
CN116829132A (zh) 2020-12-30 2023-09-29 生物欧赛加有限责任公司 胶束纳米粒子及其用途

Similar Documents

Publication Publication Date Title
JP2025106480A5 (enExample)
US11020487B2 (en) Compositions for introducing nucelic acid into cells
CN105579584B (zh) 用于将rna引入细胞的组合物
JP2025126919A5 (enExample)
JP2023123491A5 (enExample)
CN109072238B (zh) 使用靶向结缔组织生长因子的rna复合物治疗特发性肺纤维化
US20210121580A1 (en) Functionalized DNA Dendrimers For Gene Delivery To Cells
US12478684B2 (en) Oligonucleotide-polymer miktoarm conjugates and methods of use
CN114317545B (zh) 一种核酸适体及其应用
Man et al. Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions
tinkaya et al. MicroRNAs and long non-coding RNAs as novel targets in Anti-cancer drug development
IL316806A (en) Compositions and methods for treating monogenic neurodevelopmental disorder
JPWO2020261227A5 (enExample)
KR20240040112A (ko) 방법
EP4323517A2 (en) Compositions containing nucleic acid nanoparticles and processes related to alteration of their physicochemical characteristics
US9579394B2 (en) Polyanion nanocomplexes for therapeutic applications
CN115210376A (zh) 诱导外显子51的跳读的反义核酸
TW202241461A (zh) 微胞奈米粒子及其用途
Nomani et al. Poly (amido amine) dendrimer silences the expression of epidermal growth factor receptor and p53 gene in vitro
US20200347385A1 (en) METHOD FOR mRNA STABILIZATION
Duong et al. RNA therapeutics history and future perspectives
WO2024147020A1 (en) Polymersomes for delivery of nucleic acid cargoes
KR20240072931A (ko) 히스티딘을 포함하는 지질 나노입자 및 그 제조방법
JPWO2022144811A5 (enExample)
Jorge et al. Oligonucleotide conjugates and DNA nanotechnology